Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Anticancer Research
|
August 19, 2007
Chemosensitivity-related genes of breast cancer detected by DNA microarray
Tadashi Ikeda, Hiromitsu Jinno, Masatoshi Shirane
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 19, 2010
[Microarray analysis of tumor xenograft model]
Fumiko Fujita, Masatoshi Shirane, Kazushige Mori, et al.
Cancer Chemotherapy and Pharmacology
|
September 30, 2006
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models
Kaori Fujimoto-Ouchi, Etsuro Onuma, Masatoshi Shirane, et al.
Oncology Reports
|
January 3, 2012
Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
Toshiki Iwai, Yoichiro Moriya, Masatoshi Shirane, et al.
Oncology Reports
|
September 30, 2010
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
Koh Furugaki, Toshiki Iwai, Masatoshi Shirane, et al.
Anticancer Research
|
March 2, 2005
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma
Kenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2009
Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy
Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Kaname Yamamoto, et al.
Oncology Letters
|
September 12, 2012
High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers
Shinobu Umemura, Masatoshi Shirane, Susumu Takekoshi, et al.
Molecular Medicine Reports
|
April 8, 2011
Effect of erythropoietin on human tumor growth in xenograft models
Motoyuki Kataoka, Yoichiro Moriya, Yoshiyuki Moriguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway
Kenji Hibi, Shin-ichi Fujitake, Tsunenobu Takase, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Anticancer Research
|
August 19, 2007
Chemosensitivity-related genes of breast cancer detected by DNA microarray
Tadashi Ikeda, Hiromitsu Jinno, Masatoshi Shirane
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 19, 2010
[Microarray analysis of tumor xenograft model]
Fumiko Fujita, Masatoshi Shirane, Kazushige Mori, et al.
Cancer Chemotherapy and Pharmacology
|
September 30, 2006
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models
Kaori Fujimoto-Ouchi, Etsuro Onuma, Masatoshi Shirane, et al.
Oncology Reports
|
January 3, 2012
Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts
Toshiki Iwai, Yoichiro Moriya, Masatoshi Shirane, et al.
Oncology Reports
|
September 30, 2010
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS
Koh Furugaki, Toshiki Iwai, Masatoshi Shirane, et al.
Anticancer Research
|
March 2, 2005
Plasminogen activator inhibitor-1 is a downstream mediator of the PGP9.5-related oncogenic pathway in esophageal squamous cell carcinoma
Kenji Hibi, Yasuhiro Kodera, Katsuki Ito, et al.
Cancer Chemotherapy and Pharmacology
|
November 12, 2009
Preclinical study of prolonged administration of trastuzumab as combination therapy after disease progression during trastuzumab monotherapy
Kaori Fujimoto-Ouchi, Fumiko Sekiguchi, Kaname Yamamoto, et al.
Oncology Letters
|
September 12, 2012
High expression of thymidine phosphorylase in basal-like breast cancers: Stromal expression in EGFR- and/or CK5/6-positive breast cancers
Shinobu Umemura, Masatoshi Shirane, Susumu Takekoshi, et al.
Molecular Medicine Reports
|
April 8, 2011
Effect of erythropoietin on human tumor growth in xenograft models
Motoyuki Kataoka, Yoichiro Moriya, Yoshiyuki Moriguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2003
Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway
Kenji Hibi, Shin-ichi Fujitake, Tsunenobu Takase, et al.
Page
of 2